NR 566 Week 7 Presentation

11 August 2024

Presentation: Management of Psychiatric Conditions in Primary Care - Attention-Deficit/Hyperactivity Disorder (ADHD)

Presented by: Dharmistha Patel Course: NR 566 - Advanced Pharmacology for Primary Care Instructor: Dr. Landry Institution: Chamberlain College of Nursing Date: [Insert Date]

Slide 1: Title Slide

  • Title: Management of Psychiatric Conditions in Primary Care: ADHD
  • Presented by: Dharmistha Patel
  • Course: NR 566 - Advanced Pharmacology for Primary Care
  • Institution: Chamberlain College of Nursing

Slide 2: Introduction

  • Overview of ADHD:
    • A neurodevelopmental disorder characterized by inattention, hyperactivity, and impulsivity.
    • Prevalence in both children and adults, often persisting into adulthood.
    • Impact on academic performance, social interactions, and overall quality of life.

Slide 3: Patient Scenario

  • Patient Profile:
    • Name: David S.
    • Age: 20 years old
    • Occupation: Third-year college student
    • Referral Reason: Referred due to recent anger outbursts and academic underachievement.
  • Chief Complaints:
    • Difficulty concentrating in class, wandering mind, easy frustration.
  • Social History:
    • Smokes cigarettes, daily marijuana use, increasing alcohol consumption.

Slide 4: Medical and Family History

  • Medical History:
    • Diagnosed with ADHD in 2020.
    • History of anxiety and seasonal allergies.
  • Family Medical History:
    • Father: Hypertension
    • Mother: ADHD
  • Current Medications:
    • Adderall 5 mg once daily
    • Multivitamin

Slide 5: Treatment Plan - Therapy and Counseling

  • Behavior Therapy/Psychological Counseling:
    • Strategies to manage behavior and improve coping skills.
  • Cognitive Behavioral Therapy (CBT):
    • Address dysfunctional thinking and behaviors.
  • Support Groups:
    • Peer support and shared experiences.
  • Family Therapy/Counseling:
    • Involvement of family in the treatment process.

Slide 6: Treatment Plan - Medication Management

  • Current Prescription:
    • Increase Adderall dose from 5 mg once a day to 5 mg twice a day.
  • Patient Education:
    • Discuss the new dosing schedule and potential side effects.
    • Emphasize the importance of adherence to medication.

Slide 7: Substance Use and Mental Health

  • Addressing Substance Use:
    • Discuss the impact of marijuana and alcohol on ADHD and overall mental health.
    • Provide resources and support for reducing substance dependence.

Slide 8: State and Federal Regulations

  • State of Practice: Illinois
    • Review scope of practice for FNPs regarding mental health management.
    • Ensure compliance with state and federal regulations on controlled substances.

Slide 9: Follow-Up and Monitoring

  • Regular Follow-Up:
    • Monitor the effectiveness of the increased Adderall dose.
    • Assess progress in reducing substance use.
  • Continued Support:
    • Ongoing counseling and family support.
    • Adjust treatment plan as needed based on patient response.

Slide 10: Conclusion

  • Key Takeaways:
    • Comprehensive ADHD management includes medication, therapy, and patient education.
    • Addressing substance use is critical to the success of ADHD treatment.
    • Regular monitoring and adherence to regulations ensure effective care.

References: